Rapid de novo discovery of peptidomimetic affinity reagents for human angiotensin converting enzyme 2

<jats:title>Abstract</jats:title><jats:p>Rapid discovery and development of serum-stable, selective, and high affinity peptide-based binders to protein targets are challenging. Angiotensin converting enzyme 2 (ACE2) has recently been identified as a cardiovascular disease biomarker...

Full description

Bibliographic Details
Main Authors: Zhang, Genwei, Brown, Joseph S, Quartararo, Anthony J, Li, Chengxi, Tan, Xuyu, Hanna, Stephanie, Antilla, Sarah, Cowfer, Amanda E, Loas, Andrei, Pentelute, Bradley L
Other Authors: Massachusetts Institute of Technology. Department of Chemistry
Format: Article
Language:English
Published: Springer Science and Business Media LLC 2022
Online Access:https://hdl.handle.net/1721.1/141198
_version_ 1811072345189646336
author Zhang, Genwei
Brown, Joseph S
Quartararo, Anthony J
Li, Chengxi
Tan, Xuyu
Hanna, Stephanie
Antilla, Sarah
Cowfer, Amanda E
Loas, Andrei
Pentelute, Bradley L
author2 Massachusetts Institute of Technology. Department of Chemistry
author_facet Massachusetts Institute of Technology. Department of Chemistry
Zhang, Genwei
Brown, Joseph S
Quartararo, Anthony J
Li, Chengxi
Tan, Xuyu
Hanna, Stephanie
Antilla, Sarah
Cowfer, Amanda E
Loas, Andrei
Pentelute, Bradley L
author_sort Zhang, Genwei
collection MIT
description <jats:title>Abstract</jats:title><jats:p>Rapid discovery and development of serum-stable, selective, and high affinity peptide-based binders to protein targets are challenging. Angiotensin converting enzyme 2 (ACE2) has recently been identified as a cardiovascular disease biomarker and the primary receptor utilized by the severe acute respiratory syndrome coronavirus 2. In this study, we report the discovery of high affinity peptidomimetic binders to ACE2 via affinity selection-mass spectrometry (AS-MS). Multiple high affinity ACE2-binding peptides (ABP) were identified by selection from canonical and noncanonical peptidomimetic libraries containing 200 million members (dissociation constant, <jats:italic>K</jats:italic><jats:sub>D</jats:sub> = 19–123 nM). The most potent noncanonical ACE2 peptide binder, ABP N1 (<jats:italic>K</jats:italic><jats:sub>D</jats:sub> = 19 nM), showed enhanced serum stability in comparison with the most potent canonical binder, ABP C7 (<jats:italic>K</jats:italic><jats:sub>D</jats:sub> = 26 nM). Picomolar to low nanomolar ACE2 concentrations in human serum were detected selectively using ABP N1 in an enzyme-linked immunosorbent assay. The discovery of serum-stable noncanonical peptidomimetics like ABP N1 from a single-pass selection demonstrates the utility of advanced AS-MS for accelerated development of affinity reagents to protein targets.</jats:p>
first_indexed 2024-09-23T09:04:31Z
format Article
id mit-1721.1/141198
institution Massachusetts Institute of Technology
language English
last_indexed 2024-09-23T09:04:31Z
publishDate 2022
publisher Springer Science and Business Media LLC
record_format dspace
spelling mit-1721.1/1411982023-04-19T20:00:11Z Rapid de novo discovery of peptidomimetic affinity reagents for human angiotensin converting enzyme 2 Zhang, Genwei Brown, Joseph S Quartararo, Anthony J Li, Chengxi Tan, Xuyu Hanna, Stephanie Antilla, Sarah Cowfer, Amanda E Loas, Andrei Pentelute, Bradley L Massachusetts Institute of Technology. Department of Chemistry Koch Institute for Integrative Cancer Research at MIT Massachusetts Institute of Technology. Center for Environmental Health Sciences <jats:title>Abstract</jats:title><jats:p>Rapid discovery and development of serum-stable, selective, and high affinity peptide-based binders to protein targets are challenging. Angiotensin converting enzyme 2 (ACE2) has recently been identified as a cardiovascular disease biomarker and the primary receptor utilized by the severe acute respiratory syndrome coronavirus 2. In this study, we report the discovery of high affinity peptidomimetic binders to ACE2 via affinity selection-mass spectrometry (AS-MS). Multiple high affinity ACE2-binding peptides (ABP) were identified by selection from canonical and noncanonical peptidomimetic libraries containing 200 million members (dissociation constant, <jats:italic>K</jats:italic><jats:sub>D</jats:sub> = 19–123 nM). The most potent noncanonical ACE2 peptide binder, ABP N1 (<jats:italic>K</jats:italic><jats:sub>D</jats:sub> = 19 nM), showed enhanced serum stability in comparison with the most potent canonical binder, ABP C7 (<jats:italic>K</jats:italic><jats:sub>D</jats:sub> = 26 nM). Picomolar to low nanomolar ACE2 concentrations in human serum were detected selectively using ABP N1 in an enzyme-linked immunosorbent assay. The discovery of serum-stable noncanonical peptidomimetics like ABP N1 from a single-pass selection demonstrates the utility of advanced AS-MS for accelerated development of affinity reagents to protein targets.</jats:p> 2022-03-15T18:43:04Z 2022-03-15T18:43:04Z 2022-12 2022-03-15T18:36:03Z Article http://purl.org/eprint/type/JournalArticle https://hdl.handle.net/1721.1/141198 Zhang, Genwei, Brown, Joseph S, Quartararo, Anthony J, Li, Chengxi, Tan, Xuyu et al. 2022. "Rapid de novo discovery of peptidomimetic affinity reagents for human angiotensin converting enzyme 2." Communications Chemistry, 5 (1). en 10.1038/s42004-022-00625-3 Communications Chemistry Creative Commons Attribution 4.0 International license https://creativecommons.org/licenses/by/4.0/ application/pdf Springer Science and Business Media LLC Nature
spellingShingle Zhang, Genwei
Brown, Joseph S
Quartararo, Anthony J
Li, Chengxi
Tan, Xuyu
Hanna, Stephanie
Antilla, Sarah
Cowfer, Amanda E
Loas, Andrei
Pentelute, Bradley L
Rapid de novo discovery of peptidomimetic affinity reagents for human angiotensin converting enzyme 2
title Rapid de novo discovery of peptidomimetic affinity reagents for human angiotensin converting enzyme 2
title_full Rapid de novo discovery of peptidomimetic affinity reagents for human angiotensin converting enzyme 2
title_fullStr Rapid de novo discovery of peptidomimetic affinity reagents for human angiotensin converting enzyme 2
title_full_unstemmed Rapid de novo discovery of peptidomimetic affinity reagents for human angiotensin converting enzyme 2
title_short Rapid de novo discovery of peptidomimetic affinity reagents for human angiotensin converting enzyme 2
title_sort rapid de novo discovery of peptidomimetic affinity reagents for human angiotensin converting enzyme 2
url https://hdl.handle.net/1721.1/141198
work_keys_str_mv AT zhanggenwei rapiddenovodiscoveryofpeptidomimeticaffinityreagentsforhumanangiotensinconvertingenzyme2
AT brownjosephs rapiddenovodiscoveryofpeptidomimeticaffinityreagentsforhumanangiotensinconvertingenzyme2
AT quartararoanthonyj rapiddenovodiscoveryofpeptidomimeticaffinityreagentsforhumanangiotensinconvertingenzyme2
AT lichengxi rapiddenovodiscoveryofpeptidomimeticaffinityreagentsforhumanangiotensinconvertingenzyme2
AT tanxuyu rapiddenovodiscoveryofpeptidomimeticaffinityreagentsforhumanangiotensinconvertingenzyme2
AT hannastephanie rapiddenovodiscoveryofpeptidomimeticaffinityreagentsforhumanangiotensinconvertingenzyme2
AT antillasarah rapiddenovodiscoveryofpeptidomimeticaffinityreagentsforhumanangiotensinconvertingenzyme2
AT cowferamandae rapiddenovodiscoveryofpeptidomimeticaffinityreagentsforhumanangiotensinconvertingenzyme2
AT loasandrei rapiddenovodiscoveryofpeptidomimeticaffinityreagentsforhumanangiotensinconvertingenzyme2
AT pentelutebradleyl rapiddenovodiscoveryofpeptidomimeticaffinityreagentsforhumanangiotensinconvertingenzyme2